These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10509317)

  • 41. ACP Journal Club. Tamoxifen for 5 years reduced 16-year risk for breast cancer in women at increased risk.
    Parsons H; Stearns V
    Ann Intern Med; 2015 May; 162(10):JC11. PubMed ID: 25984872
    [No Abstract]   [Full Text] [Related]  

  • 42. Retinoids and breast cancer.
    Band PR; Coldman AJ; Deschamps M
    Prog Clin Biol Res; 1990; 354A():361-77. PubMed ID: 2247499
    [No Abstract]   [Full Text] [Related]  

  • 43. Breast cancer: tamoxifen - offering a long-term prevention option.
    Errico A
    Nat Rev Clin Oncol; 2015 Feb; 12(2):66. PubMed ID: 25583681
    [No Abstract]   [Full Text] [Related]  

  • 44. IBIS-I tamoxifen update: maturity brings questions.
    Chlebowski RT
    Lancet Oncol; 2015 Jan; 16(1):7-9. PubMed ID: 25497695
    [No Abstract]   [Full Text] [Related]  

  • 45. Strengths and limitations of breast cancer risk assessment.
    Baltzell K; Wrensch MR
    Oncol Nurs Forum; 2005 May; 32(3):605-16. PubMed ID: 15897935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Confusion reigns over breast cancer.
    Birmingham K
    Nat Med; 2001 Dec; 7(12):1266. PubMed ID: 11726953
    [No Abstract]   [Full Text] [Related]  

  • 47. [Tamoxifen is effective in preventing breast cancer but the optimal length of treatment is not yet known].
    Nordenskjöld B; Hatschek T; Carstensen J
    Lakartidningen; 1990 Jan; 87(4):186. PubMed ID: 2299926
    [No Abstract]   [Full Text] [Related]  

  • 48. Tamoxifen for the prevention of breast cancer in the high-risk woman.
    Morrow M; Jordan VC
    Ann Surg Oncol; 2000; 7(1):67-71. PubMed ID: 10674451
    [No Abstract]   [Full Text] [Related]  

  • 49. [Carcinoma of the breast. Epidemiologic studies].
    Merletti F; Terracini B
    Minerva Chir; 1988 Sep; 43(18 Suppl):1-4. PubMed ID: 3226588
    [No Abstract]   [Full Text] [Related]  

  • 50. Integrating tools for breast cancer risk assessment, risk reduction, and early detection.
    Ward EM; Smith RA
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2428-9. PubMed ID: 20929880
    [No Abstract]   [Full Text] [Related]  

  • 51. Re: Prospective study of vitamin D and cancer mortality in the United States.
    Grant WB
    J Natl Cancer Inst; 2008 Jun; 100(11):826. PubMed ID: 18505972
    [No Abstract]   [Full Text] [Related]  

  • 52. Poor risk assessment limits breast cancer survival.
    Reinke T
    Manag Care; 2013 Sep; 22(9):6-7. PubMed ID: 24164004
    [No Abstract]   [Full Text] [Related]  

  • 53. Organizing to improve the management of a disease: an overview of the breast-cancer networks.
    Kane R
    Prog Clin Biol Res; 1983; 120():211-30. PubMed ID: 6878281
    [No Abstract]   [Full Text] [Related]  

  • 54. Why is breast cancer chemoprevention such a hard sell?
    Peres J
    J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815870
    [No Abstract]   [Full Text] [Related]  

  • 55. Deaths from breast cancer. 1991.
    Wkly Epidemiol Rec; 1994 Jun; 69(25):185-7. PubMed ID: 8068537
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of thermography in breast cancer.
    Samaras CA; Greenblatt RB
    Contemp Surg; 1983 Apr; 22(4):31-9. PubMed ID: 10260720
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparison of the power of two tests for qualitative interactions.
    Piantadosi S; Gail MH
    Stat Med; 1993 Jul; 12(13):1239-48. PubMed ID: 8210823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of cancer in female orthopaedic surgeons in the United States.
    Chou LB; Cox CA; Tung JJ; Harris AH; Brooks-Terrell D; Sieh W
    J Bone Joint Surg Am; 2010 Jan; 92(1):240-4. PubMed ID: 20048119
    [No Abstract]   [Full Text] [Related]  

  • 59. [What does a 50 percent reduction of risk mean? Results from clinical trials are often misleading].
    Enkvist C; Werkö L
    Lakartidningen; 1994 Mar; 91(11):1091-2. PubMed ID: 8139338
    [No Abstract]   [Full Text] [Related]  

  • 60. Breast cancer prevention: an opportunity for better understanding of time-challenged risk factors.
    Masood S
    Breast J; 2001; 7(5):277. PubMed ID: 11906436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.